0000000001265219

AUTHOR

Andrea Bizzi

showing 1 related works from this author

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations.

2008

Gabriele Nicolini1, Nicola Scichilone2, Andrea Bizzi3, Alberto Papi4, Leonardo M Fabbri51Medical Department, Chiesi Farmaceutici, Parma, Italy; 2University of Palermo, DIMPEFINU, Palermo, Italy; 3Department of Scientific Affairs, Chiesi Farmaceutici, Parma, Italy; 4Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; 5Section of Respiratory Diseases, University of Modena, Modena, ItalyAbstract: Drugs for asthma and other chronic obstructive diseases of the lungs should be preferably delivered by the inhalation route to match therapeutic effects with low systemic exposure. Inhaled drugs are delivered to the lungs via different devices, mainly metered dose inhalers and d…

medicine.medical_specialtyextrafinemoduliteformoterolFormotertolRM1-950ReviewSettore MED/10 - Malattie Dell'Apparato RespiratorioPharmacologybeclomethasoneModuliteExtrafineMedicineBeclomethasone; Extrafine; Formotertol; Modulite;Pharmacology (medical)In patientGeneral Pharmacology Toxicology and PharmaceuticsIntensive care medicineAsthmaChemical Health and SafetyInhalationbusiness.industryInhalerTherapeutic effectBeclomethasoneGeneral Medicinemedicine.diseaserespiratory tract diseasesDry powderDrug deliveryasthma therapyTherapeutics. PharmacologyFormoterolbusinessSafety Researchmedicine.drug
researchProduct